The artificial sweetener erythritol and cardiovascular event risk
Marco Witkowski(Cleveland Clinic), Stanley L. Hazen(Cleveland Clinic), Yuping Wu(Cleveland State University), Arash Haghikia(German Centre for Cardiovascular Research), Elisabeth Steinhagen‐Thiessen(Charité - Universitätsmedizin Berlin), Nisreen Nimer(Cleveland Clinic Lerner College of Medicine), Nilaksh Gupta(Cleveland Clinic Lerner College of Medicine), Tomáš Čajka(Czech Academy of Sciences), W.H. Wilson Tang(Cleveland Clinic), Jennifer Wilcox(Cleveland Clinic Lerner College of Medicine), Ina Nemet(Cleveland Clinic Lerner College of Medicine), Xinmin S. Li(Cleveland Clinic), Prasenjit Prasad Saha(Cleveland Clinic Lerner College of Medicine), Hassan S. Alamri(Cleveland Clinic Lerner College of Medicine), Maximilian König(Charité - Universitätsmedizin Berlin), Ilja Demuth(Charité - Universitätsmedizin Berlin), Ulf Landmesser(Deutsches Herzzentrum der Charité), Oliver Fiehn(University of California, Davis)
Cited by 205
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis
|Nature Methods|2015|3.4k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k